SANUWAVE Health Inc (OTCPK:SNWV)
$ 0.028 0.003285 (13.29%) Market Cap: 33.08 Mil Enterprise Value: 59.70 Mil PE Ratio: 28.00 PB Ratio: 0 GF Score: 0/100

Q2 2024 SANUWAVE Health Inc Earnings Call Transcript

Aug 13, 2024 / 12:30PM GMT
Release Date Price: $0.016 (+3.90%)

Key Points

Positve
  • SANUWAVE Health Inc (SNWV) achieved the highest quarterly revenue in company history for Q2 2024.
  • Revenue growth of 53% year-on-year, totaling $7.2 million for Q2 2024.
  • Gross margins stabilized at 73%, despite additional costs from new contract manufacturers.
  • Net income for Q2 2024 was $6.6 million, a significant improvement from a net loss of $7.3 million in Q2 2023.
  • Adjusted EBITDA improved to $1.5 million from $171,000 in the same period last year.
Negative
  • Operating expenses increased by $706,000 year-on-year, totaling $3.2 million for Q2 2024.
  • Termination of the merger with SEPA due to the inability to acquire a national securities exchange listing.
  • Current assets decreased to $8.7 million as of June 30, 2024, from $9.8 million as of December 31, 2023.
  • Cash and cash equivalents dropped to $2.5 million as of June 30, 2024.
  • The company is planning a reverse stock split, which can be perceived negatively by investors.
Operator

Good day, everyone, and welcome to SANUWAVE announces highest quarterly revenue in company history Q2 2024 Results. (Operator Instructions). Later you will have the opportunity to ask questions during the question-and-answer session. (Operator Instructions). Please note that this call may be recorded. (Operator Instructions)

It is now my pleasure to turn the conference over to Morgan Frank, CEO.

Morgan Frank
SANUWAVE Health Inc - Chairman of the Board, Chief Executive Officer

Welcome to SANUWAVE's Second Quarter 2024 Earnings Call. As many of you probably noticed, our Form 10-Q was filed with the SEC Monday night. Our earnings release was issued this morning and our updated presentation is made available on the website in our Investors section. Please refer to that during this presentation. Joining me on the call is Peter Sorensen, our CFO. And after the call, we will open up for Q&A.

So before we get going, let me go through the obligatory forward-looking statements disclaimer. This call may contain forward-looking statements such as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot